Montgomeryville / Palo Alto / New York / Stetlerstevenson / Billerica / Hesperia / Mannheim / L. A. / Cambridge / Holtsville / Liotta / Tetrazolium / /
Company
Brookhaven Instruments Co. / Mallinckrodt / Polymeric Drug-Delivery Systems / L. G. / Amgen Inc. / The McGraw-Hill Companies Inc. / B. / Agilent Technologies / Millipore / Davies / Balkwill / Bobrow / FMOC / Cantley L. C. / Naylor / OtBu / MTX / Miles / Quantitative Technologies Inc. / Rubens / M. S. / Pharmacia / Carlton Medical Products Ltd. / Happerfield L. C. / R. D. / D. W. / /
Country
United States / /
Currency
pence / USD / / /
Event
FDA Phase / /
Facility
Robert Langer* Massachusetts Institute of Technology / National Cancer Institute / Massachusetts Institute of Technology / / /
IndustryTerm
serum-free media / drug solutions / tolerable functional / cancer therapy / media conditions / cell culture media / cancer therapeutics / molecular weight cleavage product / Media samples / cancer treatment / Cell-conditioned media / sodium hydroxide solution / Online Monitoring / digestion media / intermediate product / tumor site / extraction solution / gamma-carboxyl site / protection / tert-butyl / peptide chain / low glucose media / scissile site / macromolecular carrier / /
Organization
National Cancer Institute / Massachusetts Institute of Technology / Biopolymer Lab / /
Person
Dane Wittrup / Marsha Moses / Grace Vydac / Frederick E. Tan / Robert Langer / Sanyong Jon / Nat / Kerr / Turk / Nova Biochem / Ying Chau / / /
Bioconjugate Chem. 2004, 15, 931−[removed]Synthesis and Characterization of Dextran-Peptide-Methotrexate Conjugates for Tumor Targeting via Mediation by Matrix